Here are four key takeaways:
1. Factors driving market growth include a higher prevalence of ankylosing spondylitis cases as well as rising awareness about diagnostics and treatments for the disease.
2. More government initiatives and efforts to improve healthcare infrastructure are fueling market growth.
3. The treatment’s escalated costs and a lack of surgeons and physiotherapists with ankylosing spondylitis expertise pose as barriers to market growth.
4. North America dominates the market because of a higher prevalence of the disease and more adoption of the disease’s treatment options.
More spine news:
17 spine, neurosurgeons on the move in August 2016
5 key notes on cost, readmissions for spinal tumor resection: Primary & metastatic
The best new opportunities for spine surgeons in value-based healthcare: Q&A with Dr. Stephen Hochschuler
